Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine

NCT ID
NCT07849283
Registry status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Sohag University
Conditions
Cognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Efficacy of Adding Cognitive Behavioral Therapy to Medical Treatment on Functional Ability of Patients With Vestibular Migraine

Enrollment: 60 participants (Estimated).

What is being studied

  • Drug: •Group A: Patients will receive Medical treatment only: Beta-blockers (Propranolol) , Calcium channel blockers
  • Intervention: Alcohols
  • Intervention: Amines
  • Intervention: Amino Alcohols
  • Intervention: Calcium Channel Blockers
  • Intervention: Calcium-Regulating Hormones and Agents
  • Intervention: Cardiovascular Agents
  • Intervention: Chemical Actions and Uses
  • Drug: Group B: Cognitive Behavioral Therapy (CBT) +Medical treatment
  • Intervention: Hydrocarbons
  • Intervention: Hydrocarbons, Aromatic
  • Intervention: Hydrocarbons, Cyclic
  • Intervention: Membrane Transport Modulators
  • Intervention: Molecular Mechanisms of Pharmacological Action
  • Intervention: Naphthalenes
  • Intervention: Organic Chemicals
  • Intervention: Pharmacologic Actions
  • Intervention: Phenoxypropanolamines
  • Intervention: Physiological Effects of Drugs
  • Intervention: Polycyclic Aromatic Hydrocarbons
  • Intervention: Polycyclic Compounds
  • Intervention: Propanolamines
  • Intervention: Propanols
  • Intervention: Propranolol
  • Intervention: Therapeutic Uses

Who may be eligible

Ages
18 Years to 60 Years
Sex
All
Healthy volunteers accepted
Yes

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Age: 18-60 years. Patients with a confirmed diagnosis of Vestibular Migraine according to ICHD-3 (Not better accounted by another vestibular disorder or another disease) Psychological state: Patients with stable general and psychological condition. Exclusion Criteria: * Age: below 18, above 60 years Other Vestibular Disorders as Ménière's disease, Benign Paroxysmal Positional Vertigo, Vestibular neuritis and Central neurological disorder Systemic or Other Causes Orthostatic hypotension Anxiety/panic disorders Drug-induced dizziness Psychological state: Patients with active psychiatric disorders requiring immediate intervention. Pregnancy, lactating woman and Cognitive impairment patient

Study locations

1 study location is listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Egypt

Sample of listed locations

  • Sohag University — Sohag, Egypt — Site recruitment status not specified in the registry data

Study details

Start date
November 1, 2026
Primary completion date
February 1, 2027
Completion date
March 1, 2027
First posted
September 30, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07849283
Registry last updated
September 30, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07849283 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Migraines studies | Clinical trial FAQ